BB Biotech AG (0JYO)
LSE
Closed
Oct 7, 2026
Day's Range
49.0052 wk Range
37.30Overview - 0JYO - BB Biotech AG
Key Statistics
Valuation
Enterprise Value
-5.52M
Price / Book
‪1.37‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-188,166.67%‬
Return on Assets
‪-0.90%‬
Return on Equity
‪-3.85%‬
Ownership
Held by Insiders
‪1.76%‬
Held by Institutions
‪7.77%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪51.27‬
200-Day Avg
‪46.55‬
Dividends
Frequency
Annual
Peers - 0JYO - BB Biotech AG
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0JYOLSEBB Biotech AG+43.33%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 0A45LSEModerna Inc.+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0RU5LSEOncoinvent ASA+98.57%52-week change350.00P/E (Trailing)‪34.25%‬Profit Margin
- 0JDKLSEIovance Biotherapeutics Inc.+84.26%52-week change25.49P/E (Trailing)‪-89.09%‬Profit Margin
- 0GQULSEActive Biotech AB+96.20%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 0RISLSECircio Holding ASA+94.15%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 0NWKLSEValerio Tx Corp.+89.13%52-week change1.27P/E (Trailing)‪-190.36%‬Profit Margin
Profile Summary - 0JYO - BB Biotech AG
About
BB Biotech AG is a Switzerland-based investment company specializing in the biotechnology sector. Founded in 1993 and headquartered in Schaffhausen, it invests primarily in publicly traded companies developing and commercializing innovative drugs that address significant unmet medical needs, such as oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
